FAIRHAVEN PHARMACEUTICALS
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions. The company offers a preclinical research program of small molecule antagonists and other related services to develop oral therapeutics, enabling clinicians to treat patients with inflammatory conditions.
FAIRHAVEN PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Status:
Active
Similar Organizations
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Paradox Pharmaceuticals
Paradox Pharmaceuticals is dedicated to safely and effectively treating cancer in companion animals.
Statim Pharmaceuticals
Statim Pharmaceuticals develops innovative drug delivery solutions that are easy to administer by anyone in emergency situations.
More informations about "Fairhaven Pharmaceuticals"
Fairhaven Pharmaceuticals - Osler, Hoskin & Harcourt LLP
On July 17, 2020, Fairhaven Pharmaceuticals announced that it has been acquired by Liminal BioSciences. The acquisition includes Fairhaven’s preclinical research program of small …See details»
Fairhaven Pharmaceuticals acquired by Liminal BioSciences
Fairhaven Pharmaceuticals Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions. Acquiring Organization: Liminal BioSciences …See details»
Liminal BioSciences acquires Fairhaven Pharma to expand R&D …
Jul 17, 2020 Liminal BioSciences Inc. acquired Fairhaven Pharmaceuticals Inc. in an all-stock deal to expand its research and development program. Laval, Quebec-based Liminal …See details»
FAIRHAVEN PHARMACEUTICALS INC. :: Ontario (Canada)
Free and open company data on Ontario (Canada) company FAIRHAVEN PHARMACEUTICALS INC. (company number 1996919), Laval, QuebecSee details»
Fairhaven Pharmaceuticals - PitchBook
Fairhaven Pharmaceuticals is headquartered in Vancouver, Canada. What industry is Fairhaven Pharmaceuticals in? Fairhaven Pharmaceuticals’s primary industry is Drug Discovery. Is …See details»
Fairhaven Pharmaceuticals Inc. · 500 Boulevard Cartier
Fairhaven Pharmaceuticals Inc. is a federal corporation in Laval incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) Canada. The …See details»
Fairhaven Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Fairhaven Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Fairhaven Pharmaceuticals Inc. · 500 Boulevard Cartier Ouest, Suite …
Fairhaven Pharmaceuticals Inc. is a federal corporation in Laval, Quebec incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) …See details»
Fairhaven Pharmaceuticals - Crunchbase
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions.See details»
Fairhaven Pharmaceuticals - Products, Competitors, Financials ...
Fairhaven is a pharmaceutical company focused on developing novel, small molecule, oral therapeutics for severe inflammatory conditions. On July 17, 2020 Fairhaven Pharmaceuticals …See details»
Fairhaven Pharmaceuticals Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Fairhaven Pharmaceuticals Inc. of Laval, QC. Get the latest business insights from Dun & Bradstreet.See details»
Liminal BioSciences Inc. acquired Fairhaven Pharmaceuticals Inc.
Jul 16, 2020 Liminal BioSciences Inc. acquired Fairhaven Pharmaceuticals Inc. from Genesys Ventures III LP managed by Genesys Capital Partners Inc., MSBi Valorisation Inc., The Royal …See details»
Liminal BioSciences acquires Fairhaven Pharmaceuticals
Jul 17, 2020 Liminal BioSciences (NASDAQ, TSX:LMNL) acquired closely-held Fairhaven Pharmaceuticals for $8-million (Canadian) in common shares.. Fairhaven’s assets include a …See details»
Fairhaven Pharmaceuticals Inc. | Insights
Pharmaceuticals; Other Names/Subsidiaries. Liminal BioSciences Inc. See more in Biomedtracker. Latest on Fairhaven Pharmaceuticals Inc. Already A Biomedtracker …See details»
Liminal BioSciences Broadens R&D Pipeline With Novel
Jul 17, 2020 The Fairhaven R&D Program is based on the research of Dr. William Powell, Professor Emeritus in the Department of Medicine at McGill University, working in …See details»
Elizabeth Douville Appointed President and Chief Executive Officer …
Feb 27, 2023 She has sourced, led and overseen several investments in biotech companies, in promising academic technologies, and has successfully catalyzed the creation and syndication …See details»
Liminal BioSciences - Funding, Financials, Valuation & Investors
Their most recent acquisition was Fairhaven Pharmaceuticals on Jul 17, 2020. ... Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced …See details»
Florida Tech’s Joshua Rokach Named to National Academy of …
Dec 19, 2018 Among them are three patents jointly owned by Florida Tech and McGill University that in July 2018 were licensed to Fairhaven Pharmaceuticals, a Canadian-based start-up …See details»
Fairhaven Pharmaceuticals Stock Price, Funding, Valuation, …
Jul 17, 2020 Fairhaven Pharmaceuticals's latest funding round was a Acquired for $5.89M on July 17, 2020. Date. Round. Amount. Investors. Valuation. Valuations are submitted by …See details»
WHO calls for stronger surveillance of H5N1 bird flu among animals
1 day ago A World Health Organization official on Thursday called for stronger surveillance in animals for evidence of infection with H5N1 bird flu in order to curb its spread.See details»